Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.

Porakishvili N, Kardava L, Jewell AP, Yong K, Glennie MJ, Akbar A, Lydyard PM.

Haematologica. 2004 Apr;89(4):435-43.

2.

How do cytotoxic lymphocytes kill their targets?

Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ.

Curr Opin Immunol. 1998 Oct;10(5):581-7. Review.

PMID:
9794837
3.

Prolegomenon for chronic lymphocytic leukaemia.

Vitale B, Martinis M, Antica M, Kusić B, Rabatić S, Gagro A, Kusec R, Jaksić B.

Scand J Immunol. 2003 Dec;58(6):588-600. Review.

4.

[The role of perforin mediated cell cytotoxicity in psoriasis].

Kastelan M, Massari LP, Peternel S.

Lijec Vjesn. 2010 Nov-Dec;132(11-12):361-4. Review. Croatian.

PMID:
21294326
5.

Natural killer function in B-chronic lymphocytic leukemia.

Kay NE, Perri RT.

Nouv Rev Fr Hematol. 1988;30(5-6):343-5. Review.

PMID:
3065733
6.
7.

Potential for cytokine and product manipulation to improve the results of autologous stem cell transplantation for rheumatoid arthritis.

Talmadge JE, Singh R, Ageitos A, Buyukberber S.

J Rheumatol Suppl. 2001 Oct;64:32-8. Review.

PMID:
11642502
8.

Cytotoxic granule-mediated apoptosis: unraveling the complex mechanism.

Raja SM, Metkar SS, Froelich CJ.

Curr Opin Immunol. 2003 Oct;15(5):528-32. Review.

PMID:
14499261
9.

Immune complexes and apoptosis in B-cell chronic lymphocytic leukemia.

Gamberale R, Geffner JR, Giordano M.

Leuk Lymphoma. 2002 Feb;43(2):251-5. Review.

PMID:
11999554
10.

Aberrant responses of human lymphocytic neoplasms to cytokine regulation.

Nowell PC, Moore JS.

Immunol Res. 1998;17(1-2):171-7. Review.

PMID:
9479579
11.

Relationship between autoimmunity and immunodeficiency in CLL.

Caligaris-Cappio F.

Hematol Cell Ther. 1997 Nov;39 Suppl 1:S13-6. Review.

PMID:
9471057
12.

Clonal populations of T-cells in patients with B-cell malignancies.

Moss PA, Gillespie G.

Leuk Lymphoma. 1997 Oct;27(3-4):231-8. Review.

PMID:
9402322
13.

Biology of chronic lymphocytic leukemia.

Caligaris-Cappio F.

Rev Clin Exp Hematol. 2000 Mar;4(1):5-21. Review.

PMID:
11491097
14.

Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Jadidi-Niaragh F, Ghalamfarsa G, Yousefi M, Tabrizi MH, Shokri F.

Tumour Biol. 2013 Aug;34(4):2031-9. doi: 10.1007/s13277-013-0832-x. Epub 2013 May 17. Review.

PMID:
23681798
15.

Murine models for chronic lymphocytic leukaemia.

Michie AM, Nakagawa R, McCaig AM.

Biochem Soc Trans. 2007 Nov;35(Pt 5):1009-12. Review.

PMID:
17956265
16.

Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.

Orsini E, Guarini A, Foa R.

Rev Clin Exp Hematol. 2000 Mar;4(1):73-98. Review.

PMID:
11486331
17.

Role of the microenvironment in chronic lymphocytic leukaemia.

Caligaris-Cappio F.

Br J Haematol. 2003 Nov;123(3):380-8. Review. No abstract available.

PMID:
14616995
18.

[Idiopathic inflammatory myopathies].

Murakawa Y.

Nihon Rinsho. 2005 May;63 Suppl 5:300-4. Review. Japanese. No abstract available.

PMID:
15954366
19.

Immunologic monitoring in chronic lymphocytic leukemia.

Wierda WG.

Curr Oncol Rep. 2003 Sep;5(5):419-25. Review.

PMID:
12895395
20.

The apoptotic pathway: a target for therapy in chronic lymphocytic leukemia.

Bentley DP, Pepper CJ.

Hematol Oncol. 2000 Sep;18(3):87-98. Review.

PMID:
11027978
Items per page

Supplemental Content

Write to the Help Desk